KCNA3 and B-cell chronic lymphocytic leukemia: Employing membrane-permeable Kv1.3 inhibitors such as clofazimine, Psora 4 and PAP-1 [19,20], we showed that these Kv1.3 inhibitors efficiently kill chronic lymphocytic leukemia (B-CLL) cells.